Pier Capital LLC bought a new stake in Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 155,232 shares of the company’s stock, valued at approximately $4,151,000. Pier Capital LLC owned 0.87% of Tabula Rasa Healthcare at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the stock. TIAA CREF Investment Management LLC raised its stake in Tabula Rasa Healthcare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock valued at $110,000 after buying an additional 4,232 shares in the last quarter. Financial Consulate Inc. acquired a new stake in Tabula Rasa Healthcare in the third quarter valued at $222,000. Rhumbline Advisers acquired a new stake in Tabula Rasa Healthcare in the third quarter valued at $253,000. New York State Common Retirement Fund raised its stake in Tabula Rasa Healthcare by 257.0% in the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock valued at $151,000 after buying an additional 7,199 shares in the last quarter. Finally, Wells Fargo & Company MN raised its stake in Tabula Rasa Healthcare by 79.8% in the third quarter. Wells Fargo & Company MN now owns 12,768 shares of the company’s stock valued at $341,000 after buying an additional 5,668 shares in the last quarter. Hedge funds and other institutional investors own 31.85% of the company’s stock.
A number of research firms have weighed in on TRHC. BidaskClub cut Tabula Rasa Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Zacks Investment Research cut Tabula Rasa Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 10th. Piper Jaffray Companies restated an “overweight” rating and issued a $35.00 price target on shares of Tabula Rasa Healthcare in a research note on Tuesday, November 7th. They noted that the move was a valuation call. First Analysis began coverage on Tabula Rasa Healthcare in a research note on Wednesday, November 1st. They issued an “overweight” rating and a $41.00 price target on the stock. Finally, Wells Fargo & Company lifted their target price on Tabula Rasa Healthcare from $21.00 to $27.00 and gave the stock a “market perform” rating in a research report on Thursday, October 19th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Tabula Rasa Healthcare currently has a consensus rating of “Buy” and an average price target of $28.25.
Shares of Tabula Rasa Healthcare Inc. (NASDAQ TRHC) opened at $29.00 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.66 and a debt-to-equity ratio of 0.47. Tabula Rasa Healthcare Inc. has a 52-week low of $11.35 and a 52-week high of $36.80.
Tabula Rasa Healthcare (NASDAQ:TRHC) last posted its earnings results on Monday, November 6th. The company reported $0.08 EPS for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.02. Tabula Rasa Healthcare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The business had revenue of $33.27 million for the quarter, compared to analysts’ expectations of $31.76 million. During the same quarter in the previous year, the firm earned $0.06 earnings per share. The business’s revenue was up 37.6% compared to the same quarter last year. sell-side analysts anticipate that Tabula Rasa Healthcare Inc. will post 0.05 earnings per share for the current year.
About Tabula Rasa Healthcare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.